EcoR1 Capital, LLC Q3 2016 Filing
Filed November 14, 2016
Portfolio Value
$325.9B
Holdings
31
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (31 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | IRWDIRONWOOD PHARMACEUTICALS INC | 2,810,315 | $44.6B | 13.69% | |
| 2 | GLPGGALAPAGOS NV | 500,576 | $32.4B | 9.93% | |
| 3 | BMYBRISTOL MYERS SQUIBB CO | 500,000 | $27.0B | 8.27% | Call |
| 4 | ASMBASSEMBLY BIOSCIENCES INC | 2,943,164 | $21.2B | 6.51% | |
| 5 | —DERMIRA INC | 522,000 | $17.7B | 5.42% | |
| 6 | ARDXARDELYX INC | 1,310,023 | $17.0B | 5.20% | |
| 7 | KURAKURA ONCOLOGY INC | 2,611,906 | $16.3B | 5.01% | |
| 8 | —FIVE PRIME THERAPEUTICS INC | 286,612 | $15.0B | 4.62% | |
| 9 | FGENEURFIBROGEN INC | 686,184 | $14.2B | 4.36% | |
| 10 | GILDGILEAD SCIENCES INC | 150,000 | $11.9B | 3.64% | Call |
| 11 | —ALLERGAN PLC | 50,000 | $11.5B | 3.53% | Call |
| 12 | AGIOAGIOS PHARMACEUTICALS INC | 200,000 | $10.6B | 3.24% | |
| 13 | —PROTEOSTASIS THERAPEUTICS INC | 602,315 | $9.4B | 2.88% | |
| 14 | EXASEXACT SCIENCES CORP | 500,000 | $9.3B | 2.85% | Put |
| 15 | —ACHAOGEN INC | 1,679,707 | $8.0B | 2.47% | |
| 16 | CYTKCYTOKINETICS INC | 846,654 | $7.8B | 2.38% | |
| 17 | —KINDRED BIOSCIENCES INC | 1,432,765 | $7.1B | 2.19% | |
| 18 | SNDXSYNDAX PHARMACEUTICALS INC | 357,365 | $5.4B | 1.66% | |
| 19 | ONCBEIGENE LTD | 163,470 | $5.0B | 1.55% | |
| 20 | IRWDIRONWOOD PHARMACEUTICALS INC | 281,500 | $4.5B | 1.37% | Call |
| 21 | ASNDASCENDIS PHARMA A S | 219,200 | $4.4B | 1.35% | |
| 22 | —SPARK THERAPEUTICS INC | 68,600 | $4.1B | 1.26% | |
| 23 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 946,263 | $3.9B | 1.19% | |
| 24 | —NABRIVA THERAPEUTICS AG | 548,912 | $3.9B | 1.19% | |
| 25 | NTLAINTELLIA THERAPEUTICS INC | 200,858 | $3.4B | 1.05% | |
| 26 | CMRXEURCHIMERIX INC | 598,062 | $3.3B | 1.02% | |
| 27 | —ONCOMED PHARMACEUTICALS INC | 265,784 | $3.0B | 0.93% | |
| 28 | FATEFATE THERAPEUTICS INC | 590,527 | $1.8B | 0.57% | |
| 29 | —CHEMOCENTRYX INC | 178,000 | $1.1B | 0.33% | |
| 30 | —SYROS PHARMACEUTICALS INC | 63,596 | $882.0M | 0.27% | |
| 31 | —CASCADIAN THERAPEUTICS INC | 103,800 | $170.0M | 0.05% | Call |